E. Bajetta

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-α2b in metastatic melanoma

E. Bajetta, Michele Del Vecchio, P. Nova et al. · Annals of Oncology · 2006 · 113 citations

Multicenter Phase Iii, Medicine, Melanoma +8

Results of an interim analysis of a multinational randomized, double-blind, phase III study in patients (pts) with previously treated metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK787/ZK 222584 (PTK/ZK) or placebo (CONFIRM 2)

C. Koehne, E. Bajetta, E. Lin et al. · Journal of Clinical Oncology · 2006 · 87 citations

Surgical Oncology, Cancer Management, Pathology +25

Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer

E. Bajetta, Luigi Celio, Roberto Buzzoni et al. · Annals of Oncology · 2003 · 53 citations · Full text

Oncology, Gastrointestinal Oncology, Gastrointestinal Pharmacology +8

A clinical study of the pineal gland activity in oncologic patients

Paolo Lissoni, Simonetta Viviani, E. Bajetta et al. · Cancer · 1986 · 47 citations · Full text

Pineal Gland Activity, Melatonin Serum Levels, Oncology +14

Final results of CONFIRM 2: A multinational, randomized, double-blind, phase III study in 2nd line patients (pts) with metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK787/ZK 222584 (PTK/ZK) or placebo

C.-H. Köhne, E. Bajetta, E. Lin et al. · Journal of Clinical Oncology · 2007 · 47 citations

Pathology, Pharmacotherapy, Pre-clinical Pharmacology +21